Foghorn Therapeutics (FHTX) Share-based Compensation (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Foghorn Therapeutics | 297.63 Mn | 208.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.34% |
| Dec 31, 2025 | -18.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 1.52% |
| Mar 31, 2025 | 8.42% |
| Dec 31, 2024 | -17.73% |
| Sep 30, 2024 | -4.73% |
| Jun 30, 2024 | -1.74% |
| Mar 31, 2024 | 5.67% |
| Dec 31, 2023 | -25.48% |
| Sep 30, 2023 | -8.41% |
| Jun 30, 2023 | -2.23% |
| Mar 31, 2023 | 20.92% |
| Dec 31, 2022 | -0.55% |
| Sep 30, 2022 | 8.35% |
| Jun 30, 2022 | 8.17% |
| Mar 31, 2022 | 55.66% |
| Dec 31, 2021 | -12.07% |
| Sep 30, 2021 | 16.06% |
| Jun 30, 2021 | 8.16% |
| Mar 31, 2021 | 75.14% |
| Dec 31, 2020 | 22.92% |
| Sep 30, 2020 | 79.35% |
| Jun 30, 2020 | -5.42% |
| Mar 31, 2020 | -9.30% |
| Dec 31, 2019 | 28.67% |